These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32162772)

  • 1. QSAR Use in REACH Analyses of Alternatives to Predict Human Health and Environmental Toxicity of Alternative Chemical Substances.
    Chinen K; Malloy T
    Integr Environ Assess Manag; 2020 Sep; 16(5):745-760. PubMed ID: 32162772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-Strategy Assessment of Different Uses of QSAR under REACH Analysis of Alternatives to Advance Information Transparency.
    Chinen K; Malloy T
    Int J Environ Res Public Health; 2022 Apr; 19(7):. PubMed ID: 35410019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting PBT and CMR properties of substances of very high concern (SVHCs) using QSAR models, and application for K-REACH.
    Moon J; Lee B; Ra JS; Kim KT
    Toxicol Rep; 2020; 7():995-1000. PubMed ID: 32874922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated testing and intelligent assessment-new challenges under REACH.
    Ahlers J; Stock F; Werschkun B
    Environ Sci Pollut Res Int; 2008 Oct; 15(7):565-72. PubMed ID: 18818964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of alternatives assessment in chemicals management policies: Needs for greater impact.
    Rudisill C; Jacobs M; Roy M; Brown L; Eaton R; Malloy T; Davies H; Tickner J
    Integr Environ Assess Manag; 2024 Jul; 20(4):1035-1045. PubMed ID: 37658263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncertainty in QSAR predictions.
    Sahlin U
    Altern Lab Anim; 2013 Mar; 41(1):111-25. PubMed ID: 23614548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arguments for considering uncertainty in QSAR predictions in hazard and risk assessments.
    Sahlin U; Golsteijn L; Iqbal MS; Peijnenburg W
    Altern Lab Anim; 2013 Mar; 41(1):91-110. PubMed ID: 23614547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison between bioconcentration factor (BCF) data provided by industry to the European Chemicals Agency (ECHA) and data derived from QSAR models.
    Petoumenou MI; Pizzo F; Cester J; Fernández A; Benfenati E
    Environ Res; 2015 Oct; 142():529-34. PubMed ID: 26282223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a quantitative structure-activity relationship for chronic narcosis to fish.
    Claeys L; Iaccino F; Janssen CR; Van Sprang P; Verdonck F
    Environ Toxicol Chem; 2013 Oct; 32(10):2217-25. PubMed ID: 23775559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How in silico and QSAR approaches can increase confidence in environmental hazard and risk assessment.
    Thomas PC; Bicherel P; Bauer FJ
    Integr Environ Assess Manag; 2019 Jan; 15(1):40-50. PubMed ID: 30447098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural alerts for the identification of bioaccumulative compounds.
    Valsecchi C; Grisoni F; Consonni V; Ballabio D
    Integr Environ Assess Manag; 2019 Jan; 15(1):19-28. PubMed ID: 30024088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of substances with a carcinogenic potential in spray-formulated engine/brake cleaners and lubricating products, available in the European Union (EU) - based on IARC and EU-harmonised classifications and QSAR predictions.
    Sørli JB; Frederiksen M; Nikolov NG; Wedebye EB; Hadrup N
    Toxicology; 2022 Jul; 477():153261. PubMed ID: 35863487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (Q)SARs as Adaptations to REACH Information Requirements.
    Alasuvanto T; Gissi A; Sobanski T; Karamertzanis P; Rasenberg M
    Methods Mol Biol; 2018; 1800():107-115. PubMed ID: 29934889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using REACH for the EU Environmental Footprint: Building a Usable Ecotoxicity Database, Part I.
    Saouter E; Biganzoli F; Pant R; Sala S; Versteeg D
    Integr Environ Assess Manag; 2019 Sep; 15(5):783-795. PubMed ID: 31116000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transparency of chemical risk assessment data under REACH.
    Ingre-Khans E; Ågerstrand M; Beronius A; Rudén C
    Environ Sci Process Impacts; 2016 Dec; 18(12):1508-1518. PubMed ID: 27819710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing Options for Deriving Chemical Ecotoxicity Hazard Values for the European Union Environmental Footprint, Part II.
    Saouter E; Wolff D; Biganzoli F; Versteeg D
    Integr Environ Assess Manag; 2019 Sep; 15(5):796-807. PubMed ID: 31115961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The European Union's REACH regulation: a review of its history and requirements.
    Williams ES; Panko J; Paustenbach DJ
    Crit Rev Toxicol; 2009; 39(7):553-75. PubMed ID: 19650717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of QSARs in international decision-making frameworks to predict health effects of chemical substances.
    Cronin MT; Jaworska JS; Walker JD; Comber MH; Watts CD; Worth AP
    Environ Health Perspect; 2003 Aug; 111(10):1391-401. PubMed ID: 12896862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.